Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894407493> ?p ?o ?g. }
- W2894407493 endingPage "184" @default.
- W2894407493 startingPage "161" @default.
- W2894407493 abstract "Cancer metastasis and therapy resistance are the major unsolved clinical challenges, and account for nearly all cancer-related deaths. Both metastasis and therapy resistance are fueled by epithelial plasticity, the reversible phenotypic transitions between epithelial and mesenchymal phenotypes, including epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET). EMT and MET have been largely considered as binary processes, where cells detach from the primary tumor as individual units with many, if not all, traits of a mesenchymal cell (EMT) and then convert back to being epithelial (MET). However, recent studies have demonstrated that cells can metastasize in ways alternative to traditional EMT paradigm; for example, they can detach as clusters, and/or occupy one or more stable hybrid epithelial/mesenchymal (E/M) phenotypes that can be the end point of a transition. Such hybrid E/M cells can integrate various epithelial and mesenchymal traits and markers, facilitating collective cell migration. Furthermore, these hybrid E/M cells may possess higher tumor-initiation and metastatic potential as compared to cells on either end of the EMT spectrum. Here, we review in silico, in vitro, in vivo and clinical evidence for the existence of one or more hybrid E/M phenotype(s) in multiple carcinomas, and discuss their implications in tumor-initiation, tumor relapse, therapy resistance, and metastasis. Together, these studies drive the emerging notion that cells in a hybrid E/M phenotype may occupy 'metastatic sweet spot' in multiple subtypes of carcinomas, and pathways linked to this (these) hybrid E/M state(s) may be relevant as prognostic biomarkers as well as a promising therapeutic targets." @default.
- W2894407493 created "2018-10-05" @default.
- W2894407493 creator A5002624516 @default.
- W2894407493 creator A5009353114 @default.
- W2894407493 creator A5021221047 @default.
- W2894407493 creator A5033841777 @default.
- W2894407493 creator A5036939761 @default.
- W2894407493 creator A5038489185 @default.
- W2894407493 creator A5039760114 @default.
- W2894407493 creator A5040156444 @default.
- W2894407493 creator A5074426504 @default.
- W2894407493 creator A5083772852 @default.
- W2894407493 date "2019-02-01" @default.
- W2894407493 modified "2023-10-17" @default.
- W2894407493 title "Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas" @default.
- W2894407493 cites W1502590907 @default.
- W2894407493 cites W1508524141 @default.
- W2894407493 cites W1513770217 @default.
- W2894407493 cites W1517718106 @default.
- W2894407493 cites W1548498169 @default.
- W2894407493 cites W1550675315 @default.
- W2894407493 cites W1552497335 @default.
- W2894407493 cites W1581655059 @default.
- W2894407493 cites W1581943791 @default.
- W2894407493 cites W1689351220 @default.
- W2894407493 cites W1722231442 @default.
- W2894407493 cites W1763264848 @default.
- W2894407493 cites W1770499283 @default.
- W2894407493 cites W1775309324 @default.
- W2894407493 cites W1865809620 @default.
- W2894407493 cites W1875101685 @default.
- W2894407493 cites W1912392551 @default.
- W2894407493 cites W1959133412 @default.
- W2894407493 cites W1963965802 @default.
- W2894407493 cites W1964081206 @default.
- W2894407493 cites W1964442943 @default.
- W2894407493 cites W1964825240 @default.
- W2894407493 cites W1964862537 @default.
- W2894407493 cites W1965446739 @default.
- W2894407493 cites W1965568527 @default.
- W2894407493 cites W1966307963 @default.
- W2894407493 cites W1968002492 @default.
- W2894407493 cites W1968931043 @default.
- W2894407493 cites W1969198697 @default.
- W2894407493 cites W1969897031 @default.
- W2894407493 cites W1971001507 @default.
- W2894407493 cites W1971993769 @default.
- W2894407493 cites W1977075884 @default.
- W2894407493 cites W1979067350 @default.
- W2894407493 cites W1980484515 @default.
- W2894407493 cites W1980561748 @default.
- W2894407493 cites W1981223981 @default.
- W2894407493 cites W1981521674 @default.
- W2894407493 cites W1982585264 @default.
- W2894407493 cites W1982913268 @default.
- W2894407493 cites W1982995182 @default.
- W2894407493 cites W1983357205 @default.
- W2894407493 cites W1985339653 @default.
- W2894407493 cites W1989057019 @default.
- W2894407493 cites W1991025954 @default.
- W2894407493 cites W1992380352 @default.
- W2894407493 cites W1992668691 @default.
- W2894407493 cites W1992676863 @default.
- W2894407493 cites W1993450184 @default.
- W2894407493 cites W1993913242 @default.
- W2894407493 cites W1994290559 @default.
- W2894407493 cites W1994599132 @default.
- W2894407493 cites W1995744631 @default.
- W2894407493 cites W1996863944 @default.
- W2894407493 cites W1997316363 @default.
- W2894407493 cites W1997930286 @default.
- W2894407493 cites W2002654154 @default.
- W2894407493 cites W2007881573 @default.
- W2894407493 cites W2010160578 @default.
- W2894407493 cites W2010292117 @default.
- W2894407493 cites W2010619056 @default.
- W2894407493 cites W2010813562 @default.
- W2894407493 cites W2011153754 @default.
- W2894407493 cites W2012117840 @default.
- W2894407493 cites W2012152282 @default.
- W2894407493 cites W2014691022 @default.
- W2894407493 cites W2016360721 @default.
- W2894407493 cites W2017905687 @default.
- W2894407493 cites W2018960914 @default.
- W2894407493 cites W2019214567 @default.
- W2894407493 cites W2019264784 @default.
- W2894407493 cites W2020838623 @default.
- W2894407493 cites W2022616393 @default.
- W2894407493 cites W2022881840 @default.
- W2894407493 cites W2023427658 @default.
- W2894407493 cites W2024315189 @default.
- W2894407493 cites W2026932377 @default.
- W2894407493 cites W2027136090 @default.
- W2894407493 cites W2028593825 @default.
- W2894407493 cites W2029413197 @default.
- W2894407493 cites W2033617926 @default.
- W2894407493 cites W2035124021 @default.
- W2894407493 cites W2035187929 @default.